Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02454036 · ClinicalTrials.gov registry record · Phase 2
Biobehavioral Intervention in Gynecologic Oncology Patients
A Phase 2 study, sponsored by Rachel Miller.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT02454036: Completed Phase 2 study, sponsored by Rachel Miller.
NCT02454036 is a Phase 2 study that has completed, run by Rachel Miller. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02454036, a Phase 2 study, has completed, sponsored by Rachel Miller.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
Baseline self-report outcome measures will be completed and additional assessments will occur mid-treatment , post-treatment , 3 months following completion of all sessions, and 6 months following completion of all sessions. Patients and therapists will complete the evaluation measures in private (at home, in an office). At the University of Kentucky Markey Cancer Center, BBI treatment is offered in group and individual formats. The course of individual treatment varies and group treatment consists of 10 1.5-hour weekly sessions in the "intensive" phase, followed by 2 1.5-hour bi-weekly maintenance sessions. Individual treatment is one-on-one. In group treatment, there are typically 6-12 patients per group and 1 or 2 therapists. The intervention helps patients to learn adaptive coping strategies and how to apply them to daily stressors. Additional content discusses use of seeking information, enhancing social support, enhancing body esteem and intimacy, and maintaining positive changes.
Interventions
- BEHAVIORAL BBI intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-05-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02454036
The ClinicalTrials.gov registry entry for NCT02454036 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rachel Miller, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BBI intervention is the first listed.
NCT02454036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02454036 about?
NCT02454036 is a clinical study titled "Biobehavioral Intervention in Gynecologic Oncology Patients". Baseline self-report outcome measures will be completed and additional assessments will occur mid-treatment , post-treatment , 3 months following completion of all sessions, and 6 months following completion of all sessions. Patients and therapists will complete the evaluation measures in private (a...
What is the current status of trial NCT02454036?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2015-06. Estimated completion is 2017-05-18.
What interventions are being tested in trial NCT02454036?
The interventions under investigation include: BBI intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02454036?
This trial is sponsored by Rachel Miller, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.